Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THDB0206 vs Insulin Lispro in Chinese T1DM Patients
NCT07282054Phase 3Completed
- Sponsor
- Tonghua Dongbao
- Start
- Apr 2022
- Primary completion
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of BioChaperone Lispro in type 1 diabetes mellitus (T1D), sponsored by Tonghua Dongbao. Started Apr 2022; status: completed.
02
Drugs
BioChaperone Lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07282054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07282054.